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Methodological shortcomings in the original studies prevented this review from reaching a 
firm conclusion on the lasting benefits of residential therapeutic communities, though it 
was clear that while residents stayed, substance use was significantly reduced.
Summary Therapeutic communities are a type of drug-free residential service. Their 
objectives include maintaining abstinence and socially rehabilitating drug users. Unlike 
some other residential facilities with similar aims, in these communities the therapeutic 
system is based on treatment stages which afford residents increasing degrees of 
personal and social responsibility for the running of the service. Peer influence mediated 
through group processes is used to help individuals assimilate social norms and develop 
social skills, and social rehabilitation is promoted by daily activities. Residents have the 
opportunity to progress in the hierarchy to themselves managing group activities as a 
peer leader.
A previous systematic review found little evidence that therapeutic communities 
significantly improved on outcomes from other types of residential treatment, or that one 
type of therapeutic community was more effective than another. However, this review 
included services in prison or offered as an alternative to prison, possibly not comparable 
to those voluntary entered outside prison. It was also limited to studies which randomly 
allocated participants to therapeutic communities versus alternative or no treatments, 
and did not seek to establish which types of substance users might be best suited to 
therapeutic communities.
Using a similar methodology, the featured review focused on therapeutic communities for 
adult substance users outside the criminal justice system. Aims were to assess their 
effectiveness in terms of completion and retention in treatment as well as substance use, 
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and to determine if any characteristics were associated with greater success in achieving 
abstinence. Studies had to report relevant outcomes and be available in English or French 
up to the end of January 2011, but not necessarily to have randomly allocated 
participants to therapeutic communities versus an alternative.
Twelve such studies were found investigating outcomes from 61 therapeutic communities 
and 3271 participants. All but two studies were conducted in the Americas, and in all but 
two cocaine was the dominant problem drug. Differences between the studies were such 
that it was not appropriate to combine their findings in a meta-analysis. 
Main findings
Reported in all the studies, average retention in the communities ranged from 38 to 180 
days, representing 30% of the expected programme duration. Six studies also assessed 
the proportion of residents who completed their programmes, ranging from 9% to 56%; 
27–70% stayed at least half the expected time.
Follow-up periods during which outcomes were assessed varied from six months after 
entering the communities to six years after discharge. In all the studies substance use 
decreased during the programme or after discharge. Nevertheless, during follow-up 
periods, 21–100% of subjects had used substances or met criteria for relapse.
The post-discharge period was reported on in eight studies, most often (three studies 
and four communities) the six months after leaving. Over this period, in one study 34% 
of former residents had used substances in the previous 30 days, and cannabis use and 
drinking had both fallen significantly. In another, after staying in a community with a 
three-month programme, 48% of former residents had relapsed, compared to 41% when 
the programme was six months. Lastly, over a three-month window during the six-month 
follow-up, 33–41% of former residents of another community reported use of cocaine, 
34–35% alcohol, 16–18% cannabis and 9–15% heroin.
The longest post-discharge follow-ups were four years in one Australian study, during 
which all the former residents had relapsed at least once at some time, and in Spain six 
years, during which 46% of former residents had relapsed, defined as substance use 
more than three times in two months, most commonly alcohol, cannabis and/or cocaine.
When residents dropped out, it was usually within the first month. Generally, residents 
dependent on heroin but not other substances were more likely than other substance 
users to complete treatment. Older residents and those in shorter programmes too were 
more likely to complete. Psychiatric disorders were unrelated to completion.
Having stayed longer in the programme was the variable most consistently associated 
with abstinence during follow-up periods. In one study too, communities with longer 
intended programmes were associated with better substance use outcomes at follow-up. 
In one US study, relapse was more common among patients who had been employed in 
the three years before starting treatment, had a history of drug injecting, or lived with a 
partner who also used substances. In another US study, cocaine dependence alone was 
more predictive of relapse than heroin combined with cocaine dependence.
In the three studies to have assessed this, after leaving 20–33% of former residents re-
entered treatment of some kind during follow-up periods. 
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The authors' conclusions
Depending on the length of the treatment period, this review documented positive 
outcomes in the form of significant decreases in substance use during therapeutic 
community stays, though whether this was also the case after leaving was obscured by 
methodological issues. Most studies found low treatment completion rates, and that 
residents who left usually did so soon after starting the programme.
In more detail, all studies found decreased substance use during the programme and 
after discharge. During follow-up periods, 21–100% of subjects had used substances or 
met criteria for relapse and 20–33% had started another treatment episode. Longer 
retention best predicted abstinence at follow-up. Completion was most likely among older 
residents and in shorter programmes but was unrelated to psychiatric disorders.
It was clear that substance use was depressed during stays in the communities, but 
whether relapse continued to be prevented in the follow-up periods was unclear because 
of different definitions, and an inability to determine whether relapse was to the main 
problem drug or to another substance. These methodological limitations may explain the 
great variability of relapse rate across studies, casting doubt on the degree to which the 
results can be relied on as indicators of the benefit to be expected from such 
programmes.
Compared to other types of treatment, therapeutic communities do not appear to offer 
significant extra benefits, but might represent a better option for patients with severe 
psychosocial problems, depending on whether they stay long enough in the programme. 
 This review attempted to clarify the indecisive verdict of an earlier review 
by including non-randomised studies and eliminating a presumed major source of 
variability – whether the community was in the context of a prison or other sentencing 
option. Still, it too was indecisive in respect of lasting impacts, firmly concluding only that 
while residents stay, they use substances less often than before they entered. This in 
itself is a worthwhile achievement, but one considerably diluted by the review's finding 
that typically stays are short because residents quickly leave. This too seemed the major 
limitation on the effectiveness of English residential rehabilitation services in an audit of 
the progress of residents in 2010–11. Reporting on that audit, England's National 
Treatment Agency for Substance Misuse stressed that residential rehabilitation works in 
concert with non-residential services, typically taking its residents after they have been 
prepared by other services, which also continue the treatment of many residents after 
they leave. From the featured review it seems that internationally it is also the case that 
for many residential rehabilitation is not the end of a treatment and addiction career but 
an episode within it, making it difficult to isolate the contribution of the residential 
element in the treatment journey.
Findings from other reviews
Compared to the earlier review which it sought in some ways to improve on, the featured 
review's search for studies was very limited – to, it seems, just one database, though a 
major one. The earlier review found little evidence that residential therapeutic 
communities were, in outcome terms, preferable to residential or non-residential 
alternatives, a result partly due to significant shortcomings in the studies, including high 
proportions of participants who were not or could not be included in the analyses.
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None of the randomised studies in that review addressed the issue of whether the therapeutic community model 
is preferable to other ways of structuring residential care outside prison. Just one of the studies directly 
addressed another key issue – whether residential care is critical to the success of therapeutic communities. If it 
is not, costs can be reduced and/or more people treated. The study capitalised on the decision in 1990 of a 
residential service in San Francisco to introduce a parallel day programme, also based on therapeutic 
community principles and scheduled to run for a year followed by aftercare. The study exemplified the main 
weakness of randomised trials of residential versus non-residential care: such studies must select patients who 
can safely and practically be sent to either option and who are willing to leave the choice to chance, yet any 
advantages of residential care are likely to be most apparent among homeless clients, those whose vulnerability 
makes non-residential care unsafe, or those with strong preferences. Given this winnowing of the caseload, not 
surprisingly, in San Francisco residential care conferred few long-term advantages. In the first six months 
(when they were at least partly protected by the residential environment) residential clients were significantly 
less likely to relapse, but over the next year the benefits from residential care dissipated while relapse rates 
among day clients remained steady. A year to a year and a half after entering treatment, about half of both 
groups had remained abstinent and about a quarter had for a period relapsed to using at least four times a 
week.
Drug and Alcohol Findings has also summarised studies comparing residential and non-
residential care. From these studies it seemed that residential settings help extricate 
residents from particularly damaging environments but the added benefits can fade after 
discharge back into the community. Those who particularly benefit have been people at 
risk of suicide and clients with relatively severe psychiatric problems, in some cases 
combined with severe employment or family problems. These and other studies support 
the general contention that more severely dependent and problematic clients 
differentially benefit from residential care. Where studies have found no added benefit for 
more severe cases this may have been because the service's caseload was limited in 
severity, or because the study set severity limits so that all the subjects could safely be 
allocated to residential or non-residential care.
Other attributes found in some studies to favour residential care include low cognitive 
functioning, homelessness, low social support, and poor employment prospects. What 
matters in any particular situation will depend on the range of problems in the caseload 
and the alternative treatments on offer. For example, if very severe cases are admitted 
beyond the capacity of any of the options, or if the caseload is unproblematic enough to 
do well whatever the treatment, then none will seem preferable. Similarly, where these 
are available, intensive non-residential options (but not routine outpatient care) may 
almost match residential settings even for severe cases.
For more on residential rehabilitation see this introduction and one-click search for relevant Findings analyses. 
Last revised 08 August 2012
 Comment on this entry•  Give us your feedback on the site (one-minute survey)
Top 10 most closely related documents on this site. For more try a subject or 
free text search
The Drug Treatment Outcomes Research Study (DTORS): final outcomes report STUDY 2009
Addressing medical and welfare needs improves treatment retention and outcomes STUDY 2005
http://findings.org.uk/count/downloads/download.php?file=Malivert_M_1.txt (4 of 5) [08/08/12 10:33:52]
Your selected document
The role of residential rehab in an integrated treatment system STUDY 2012
Systematic but simple way to determine who needs residential care STUDY 2003
For crack users, non-residential rehabilitation can match residential STUDY 2002
Promoting continuing care adherence among substance abusers with co-occurring psychiatric disorders following 
residential treatment STUDY 2008
Simple induction procedures help alcohol and drug users engage with residential rehabilitation STUDY 2001
Long-term outcomes of aftercare participation following various forms of drug abuse treatment in Scotland 
STUDY 2010
The grand design: lessons from DATOS STUDY 2002
Offenders do better in treatment if sanctions credible and clear STUDY 2005
http://findings.org.uk/count/downloads/download.php?file=Malivert_M_1.txt (5 of 5) [08/08/12 10:33:52]
